Segment Information

9 Months Ended

Mar. 31, 2012

Segments and Geographic Information [Abstract]

Segment Information [Text Block]

SEGMENT INFORMATION

The Company has four reportable segments, aligned primarily by type of product: Consumer Healthcare, Nutritionals, Rx Pharmaceuticals and API, along with an Other category. As discussed in Note 3, beginning in the third quarter of fiscal 2009, the operating results of the Company’s former Israel Consumer Products operating segment are reported as discontinued operations in the Company’s condensed consolidated statements of income and are not included in the table below for any period presented. In the third quarter of fiscal 2012, the Company incurred restructuring charges of $7,081 related to its restructuring plan in its Nutritionals segment, as further discussed in Note 15. In the first nine months of fiscal 2012, the Rx Pharmaceuticals segment incurred $3,800 of severance costs in conjunction with the Paddock acquisition, $3,200 of which was expensed in the first quarter of fiscal 2012 and $600 of which was expensed in the second quarter of fiscal 2012. In addition, the Rx Pharmaceuticals segment incurred a step-up in the value of inventory of $27,179 due to the Paddock acquisition in the first quarter of fiscal 2012. During the first quarter of fiscal 2012, the Company incurred $5,600 of acquisition-related charges as unallocated expenses. The accounting policies of each segment are the same as those described in the summary of significant accounting policies set forth in Note 1. The majority of corporate expenses, which generally represent shared services, are charged to operating segments as part of a corporate allocation. Unallocated expenses relate to certain corporate services that are not allocated to the segments.

	Consumer Healthcare		Nutritionals		Rx Pharmaceuticals		API		Other		Unallocated expenses			Total
Third Quarter 2012
Net sales	$	448,848	$	117,683	$	155,591	$	36,951	$	18,944	$	—		$	778,017
Operating income	$	74,622	$	3,674	$	69,594	$	10,874	$	1,029	$	(13,723	)	$	146,070
Amortization of intangibles	$	2,421	$	6,637	$	8,574	$	490	$	410	$	—		$	18,532
Total assets	$	1,658,231	$	952,761	$	1,066,559	$	266,786	$	95,717	$	—		$	4,040,054
Third Quarter 2011
Net sales	$	425,025	$	124,077	$	84,383	$	41,206	$	16,872	$	—		$	691,563
Operating income	$	72,204	$	17,932	$	31,141	$	11,318	$	301	$	(9,983	)	$	122,913
Amortization of intangibles	$	2,128	$	5,790	$	2,827	$	519	$	439	$	—		$	11,703
Total assets	$	1,223,242	$	981,375	$	437,745	$	266,064	$	126,268	$	—		$	3,034,694

Year-to-Date 2012
Net sales	$	1,331,806	$	365,691	$	460,414	$	127,347	$	56,224	$	—		$	2,341,482
Operating income	$	216,342	$	19,234	$	168,892	$	37,554	$	2,579	$	(36,311	)	$	408,290
Amortization of intangibles	$	6,886	$	22,739	$	23,896	$	1,507	$	1,285	$	—		$	56,313
Year-to-Date 2011
Net sales	$	1,251,125	$	380,219	$	251,250	$	118,900	$	48,906	$	—		$	2,050,400
Operating income	$	218,917	$	56,174	$	82,091	$	31,673	$	1,098	$	(23,034	)	$	366,919
Amortization of intangibles	$	6,124	$	17,383	$	8,035	$	1,527	$	1,296	$	—		$	34,365